Burrows Francis
SEC insider (Form 3/4/5 filer). CIK 0002051119. Chief Scientific Officer at Kura Oncology, Inc. (KURA). 9 reported Form 4/5 transactions since Sep 2024; latest on Sep 24, 2026. Located in SAN DIEGO, CA.
Companies Burrows Francis has filed insider reports for
- Kura Oncology, Inc. (KURA): Officer, Chief Scientific Officer
Burrows Francis
CIK: 0002051119
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Kura Oncology, Inc.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Sep 24, 2026KURA
Kura Oncology, Inc.
ExerciseDirect30K shares at avg. $6.15$185K - Sep 24, 2026KURA
Kura Oncology, Inc.
SaleDirect20.7K shares at avg. $10.83$225K - Jan 27, 2026KURA
Kura Oncology, Inc.
SaleDirect1.3K shares at avg. $8.46$11K - Jan 2, 2026KURA
Kura Oncology, Inc.
AwardDirectOption to purchase common stock
185K shares- - Dec 18, 2025KURA
Kura Oncology, Inc.
ExerciseDirect35K shares at avg. $4.80$168K - Dec 18, 2025KURA
Kura Oncology, Inc.
SaleDirect23.7K shares at avg. $9.78$232K - Jan 28, 2025KURA
Kura Oncology, Inc.
SaleDirect1.3K shares at avg. $7.87$10K - Jan 28, 2025KURA
Kura Oncology, Inc.
SaleDirect846 shares at avg. $7.87$7K - Jan 2, 2025KURA
Kura Oncology, Inc.
AwardDirectOption to purchase common stock
185K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 24, 2026 | KURA Kura Oncology, Inc. | Exercise | 30,000 | $6.15 | $184,500 | Direct |
| Sep 24, 2026 | KURA Kura Oncology, Inc. | Sale | 20,726 | $10.83 | $224,514 | Direct |
| Jan 27, 2026 | KURA Kura Oncology, Inc. | Sale | 1,311 | $8.46 | $11,092 | Direct |
| Jan 2, 2026 | KURA Kura Oncology, Inc. | Award Option to purchase common stock | 185,000 | - | - | Direct |
| Dec 18, 2025 | KURA Kura Oncology, Inc. | Exercise | 35,000 | $4.80 | $168,000 | Direct |
| Dec 18, 2025 | KURA Kura Oncology, Inc. | Sale | 23,726 | $9.78 | $231,931 | Direct |
| Jan 28, 2025 | KURA Kura Oncology, Inc. | Sale | 1,320 | $7.87 | $10,391 | Direct |
| Jan 28, 2025 | KURA Kura Oncology, Inc. | Sale | 846 | $7.87 | $6,660 | Direct |
| Jan 2, 2025 | KURA Kura Oncology, Inc. | Award Option to purchase common stock | 185,000 | - | - | Direct |
1-9 of 9 transactions